Search

Search Results

1. Messung CD34+ hämatopoetischer Stammzellen

   Die Messung von CD34+ hämatopoetischen Stammzellen (HSC) ist eine in der Hämatologie und Transfusionsmedizin häufig angeforderte Analyse. Diese dient...

   Julie Schanz, Nils Brökers in Durchflusszytometrie in der Hämatologie

   Chapter 2023
   

2. CD34+-Stammzellen und Regenerative Medizin

   Obwohl Transplantationen hämatopoetischer Stammzellen (HSCs) seit mehr als 50 Jahren täglich durchgeführt werden, wurde das Konzept der...

   Philippe Hénon, Rachid Lahlil in Stammzellen

   Chapter 2023
   

3. CD34+ synovial fibroblasts exhibit high osteogenic potential in synovial chondromatosis

   Synovial chondromatosis (SC) is a disorder of the synovium characterized by the formation of osteochondral nodules within the synovium. This study...

   **aoyu Li, Hao Sun, ... Ruofan Ma in Cell and Tissue Research

   Article 11 April 2024
   

4. CD34 Protein: Its expression and function in inflammation

   CD34 has spear-headed the field of basic research and clinical transplantation since the first reports of its expression on hematopoietic stem cells...

   Carolina Rego Rodrigues, Sahib Moga, ... Gurpreet Kaur Aulakh in Cell and Tissue Research

   Article 14 July 2023
   

5. Endothelial CD34 expression and regulation of immune cell response in-vitro

   Endothelial cells cover the lining of different blood vessels and lymph nodes, and have major functions including the transport of blood, vessel...

   Lousineh Arakelian, Julien Lion, ... Nuala Mooney in Scientific Reports

   Article Open access 19 August 2023
   

6. Multilineage contribution of CD34⁺ cells in cardiac remodeling after ischemia/reperfusion injury

   The ambiguous results of multiple CD34 ⁺ cell-based therapeutic trials for patients with heart disease have halted the large-scale application of...

   Jun **e, Liujun Jiang, ... Qingbo Xu in Basic Research in Cardiology

   Article Open access 05 May 2023
   

7. Fetal liver CD34⁺ contain human immune and endothelial progenitors and mediate solid tumor rejection in NOG mice

   Background

   Transplantation of CD34 ⁺ hematopoietic stem and progenitor cells (HSPC) into immunodeficient mice is an established method to generate...

   Teja Celhar, **nyi Li, ... Takeshi Takahashi in Stem Cell Research & Therapy

   Article Open access 09 June 2024
   

8. Development of a potency assay for CD34⁺ cell-based therapy

   We have previously shown that intracardiac delivery of autologous CD34 ⁺ cells after acute myocardial infarction (AMI) is safe and leads to long term...

   Anne Aries, Christine Vignon, ... Ibon Garitaonandia in Scientific Reports

   Article Open access 11 November 2023
   

9. Diagnostic conundrum of Superficial CD34-positive fibroblastic tumor (SCPFT): a series of five cases

   Superficial CD34-positive fibroblastic tumor (SCPFT) is an extremely rare neoplasm with an indolent behavior. It was incorporated for the first time...

   Sumanta Das, Adil Aziz Khan, ... R. Naveen Kumar in Indian Journal of Surgical Oncology

   Article 15 July 2024
   

10. TNFα induces Caspase-3 activity in hematopoietic progenitor cells CD34+, CD33+, and CD41 + of myelodysplastic syndromes

    Background

    Cytopenia is the primary feature of Myelodysplastic Syndrome, even in the presence of hypercellular bone marrow. TNFα is recognized as both...

    Anggraini Iriani, Andhika Rachman, ... Marsya Kaila Fatina in BMC Molecular and Cell Biology

    Article Open access 21 November 2023
    

11. Phase III clinical trial of autologous CD34 + cell transplantation to accelerate fracture nonunion repair

    Background

    We previously demonstrated that CD34 + cell transplantation in animals healed intractable fractures via osteogenesis and vasculogenesis; we...

    Ryosuke Kuroda, Takahiro Niikura, ... Atsuhiko Kawamoto in BMC Medicine

    Article Open access 05 October 2023
    

12. Immune reconstitution, vaccine responses, and rituximab use after ex-vivo CD34-selected myeloablative allogenic hematopoietic cell transplantation

    Myeloablative T cell depleted (CD34-selected) hematopoietic cell transplantation (HCT) is associated with less acute and chronic graft versus host...

    Giovanna Melica, Elaina Preston, ... Miguel-Angel Perales in Bone Marrow Transplantation

    Article 13 February 2024

13. Defined Human Leukemic CD34+ Liquid Cultures to Study HDAC/Transcriptional Repressor Complexes

    Defined human primary cell model systems with growth dependence on oncogenes are highly requested to investigate tumor pathogenesis and to validate...

    Roland Windisch, Sophie Kreissig, Christian Wichmann in HDAC/HAT Function Assessment and Inhibitor Development

    Protocol 2023
    

14. Evaluation of the histologic and immunohistochemical (CD34, glutamine synthetase) findings in idiopathic non-cirrhotic portal hypertension (INCPH)

    Aim

    Idiopathic non-cirrhotic portal hypertension (INCPH) is a vascular disorder of uncertain origin. Diagnosis can be challenging on liver biopsy....

    Melek Büyük, Neslihan Berker, ... Mine Güllüoğlu in Hepatology International

    Article Open access 27 March 2024
    

15. Role of CD34-immunopositive Microvascular Density in Juvenile Nasopharyngeal Angiofibroma

    Objective

    To assess the microvascular density (MVD) in juvenile nasopharyngeal angiofibroma (JNA) with CD34 immunostaining and evaluate its...

    Avinash Shekhar Jaiswal, Rakesh Kumar, ... Alok Thakar in Indian Journal of Otolaryngology and Head & Neck Surgery

    Article 20 December 2023
    

16. Identification and protective role of CD34⁺ stromal cells/telocytes in experimental autoimmune encephalomyelitis (EAE) mouse spleen

    Experimental autoimmune encephalomyelitis (EAE) is a classical animal model of human multiple sclerosis (MS) that is most commonly used to study the...

    Ganesh Dama, **aoxi Hu, ... Juntang Lin in Histochemistry and Cell Biology

    Article 04 April 2023
    

17. CD34⁺ cell atlas of main organs implicates its impact on fibrosis

    Rationale

    CD34 ⁺ cells are believed being progenitors that may be used to treat cardiovascular disease. However, the exact identity and the role of...

    **angyuan Pu, Pengwei Zhu, ... Hongkun Zhang in Cellular and Molecular Life Sciences

    Article 31 October 2022
    

18. Manufacturing of CD34 + HPC-enriched, high-purity mononuclear cell products from umbilical cord blood

    The purpose of this study was to explore methods of selectively enriching CD34 + haematopoietic progenitor cells (HPC) in mononuclear cell (MNC)...

    Liam Wynn, Marnie Grace Wilson, Christopher Leonforte in Cell and Tissue Banking

    Article 03 February 2023
    

19. Induced pluripotent and CD34+ stem cell derived myeloid cells display differential responses to particle and dust mite exposure

    Myeloid cells form an essential component of initial responses to environmental hazards and toxic exposures. The ability to model these responses in...

    Leonie F. H. Fransen, Martin O. Leonard in Scientific Reports

    Article Open access 09 June 2023
    

20. Effect of different timings of umbilical cord clam** on the level of CD34⁺ cells in full-term neonates

    Despite the fact that delayed cord clam** (DCC) is recommended by many international organizations, early cord clam** is still widely practiced...

    Mai S. Korkor, Mohamed khashaba, ... Ahmad Darwish in Scientific Reports

    Article Open access 21 December 2023